Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort

被引：0
|
作者：
Philipp Sewerin
Stefan Vordenbaeumen
Annika Hoyer
Ralph Brinks
Christian Buchbender
Falk Miese
Christoph Schleich
Sabine Klein
Matthias Schneider
Benedikt Ostendorf
机构：
[1] University Hospital Düsseldorf,Department of Rheumatology & Hiller Research Unit
[2] German Diabetes Centre,Department of Diagnostic and Interventional Radiology
[3] Institute for Biometry and Epidemiology,undefined
[4] University Hospital Düsseldorf,undefined
来源：
BMC Musculoskeletal Disorders | / 18卷
关键词：
Magnetic resonance imaging; Rheumatoid arthritis; RAMRIS; Therapy monitoring; Remission; Silent progression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Subclinical synovitis and tenosynovitis by ultrasonography (US) 7 score in patients with rheumatoid arthritis treated with synthetic drugs, in clinical remission by DAS28
    Ventura-Rios, Lucio
    Sanchez Bringas, Guadalupe
    Hernandez-Diaz, Cristina
    Cruz-Arenas, Esteban
    Burgos-Vargas, Ruben
    REUMATOLOGIA CLINICA, 2019, 15 (05): : E5 - E9
  • [42] M-FICOLIN, AN ACTIVATOR OF THE COMPLEMENT SYSTEM, PREDICTS DAS28 REMISSION IN EARLY DMARD NAIVE RHEUMATOID ARTHRITIS
    Ammitzboll, C. G.
    Jensenius, J. C.
    Ellingsen, T.
    Thiel, S.
    Horslev-Petersen, K.
    Hetland, M.
    Junker, P.
    Johansen, J.
    Ostergaard, M.
    Podenphant, J.
    Stengaard-Pedersen, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 131 - 131
  • [43] Genetic polymorphisms contribute to clinical markers as predictors of DAS remission in patients with rheumatoid arthritis (RA).
    Shadick, NA
    Weinblatt, ME
    Maher, NE
    Meyer, J
    Lekstrom-Himes, J
    Ginsburg, G
    Matthews, H
    Bilics, JA
    Karlson, JE
    Anderson, RJ
    Solomon, DH
    Coblyn, J
    Parker, A
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S549 - S549
  • [44] HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH RHEUMATOID ARTHRITIS ACHIEVING DAS28 REMISSION, IMPROVEMENT IN PHYSICAL FUNCTION AND NO RADIOGRAPHIC PROGRESSION AFTER TREATMENT WITH INTRAVENOUS GOLIMUMAB
    Westhovens, R.
    Weinblatt, M. E.
    Han, C.
    Kim, L.
    Mack, M.
    Lu, J.
    Baker, D.
    Mendelsohn, A.
    Bingham, C. O., III
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 479 - 480
  • [45] Site Variation in Early Treatment Strategies and DAS28 Remission at 6 Months in the Canadian Early Arthritis Cohort (CATCH)
    Barnabe, Cheryl
    Schieir, Orit
    Hazlewood, Glen
    Pope, Janet
    Hitchon, Carol
    Bartlett, Susan
    Boire, Gilles
    Keystone, Edward
    Tin, Diane
    Haraoui, Boulos
    Bykerk, Vivian
    Thorne, Carter
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 928 - 929
  • [46] Discrepancy Between Boolean Remission and DAS28 Remission Is Dependent on the Differences in Number of Swollen Joints and Patient Global Assessment in Daily Practice, Based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort
    Tanaka, Eiichi
    Shidara, Kumi
    Inoue, Eisuke
    Seto, Yohei
    Nakajima, Ayako
    Taniguchi, Atsuo
    Momohara, Shigeki
    Yamanaka, Hisashi
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S126 - S126
  • [47] ANTI-CARBAMYLATED PROTEIN POSITIVITY PREDICTS DAS28-REMISSION AT 12 MONTHS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: RESULTS FROM THE SINGAPORE EARLY ARTHRITIS COHORT
    Cho, J.
    Mak, A.
    Agrawal, S.
    Dhanasekaran, P.
    Teoh, L. K.
    Cheung, P.
    Lahiri, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 586 - 587
  • [48] DAS28 WITH THREE VARIABLES PERFORMANCE IN A COHORT OF RHEUMATOID ARTHRITIS PATIENTS WITH AND WITHOUT CONCOMITANT FIBROMYALGIA
    Miladi, S.
    Hiba, B. A.
    Alia, F.
    Ben Yaacoub, S.
    Bousaa, H.
    Yasmine, M.
    Ouenniche, K.
    Selma, K.
    Selma, C.
    Ben Abdelghani, K.
    Ahmad, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1343 - 1343
  • [49] YOUNG RHEUMATOID ARTHRITIS PATIENTS ARE MORE LIKELY TO BE IN SDAI OR DAS28 REMISSION IN COMPARISON TO OLDER PATIENTS AFTER ONE YEAR OF TREATMENT WITH ADALIMUMAB OR ETANERCEPT
    l'Ami, M.
    Krieckaert, C.
    Kneepkens, E.
    Plasencia, C.
    Nurmohamed, M.
    Wolbink, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 475 - 476
  • [50] Agreement Between DAS28, ACR/EULAR, SDAI, CDAI and Ultrasound Remission in Patients with Rheumatoid Arthritis Receiving Biological Treatment in Routine Care
    Brahe, Cecilie Heegaard
    Terslev, Lene
    Krabbe, Simon
    Ostergaard, Mikkel
    Rogind, Henrik
    Jensen, Hanne
    Hansen, Annette
    Norregaard, Jesper
    Jacobsen, Soren
    Ellegaard, Karen
    Fana, Viktoria
    Juul, Lars
    Huynh, Tuan K.
    Jensen, Dorte V.
    Manilo, Natalia
    Asmussen, Karsten Heller
    Brown-Frandsen, Per
    Torp-Pedersen, Soren Tobias
    Krogh, Niels Steen
    Hetland, Merete Lund
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345